Early access
Sign in
Taking people in SwitzerlandNo phase

Comparing a wrist and fingertip blood pressure device with a cuff in adults

Records optical readings from a wrist and fingertip device in adults with hypertension.

Key facts

Who runs it
Aktiia SA
Where
Lausanne, SwitzerlandSee the site
Trial code
Registry title
OBPM_COYOTE2024 Physiological Data Recording With the Calibration-free Optical Aktiia G2C Device at Fingertip and Wrist, Alongside the Aktiia Oscillometric Cuff
Status
Recruiting
People taking part
255 people, planned
Started
20 Dec 2024
Expected to end
31 Dec 2026
Type of study
Interventional
Treatments tested
  • Aktiia G2C
Record updated
14 May 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 21 to 85 who speak French and agree to one visit of about 15 minutes. An optical device is tested alongside an arm cuff.

Age
21 to 85 years
Sex
All sexes can join.

Main reasons for not taking part

  • Missing index finger or damaged skin at the index fingers or wrists
  • Fast resting heart rate (above 120bpm) or atrial fibrillation
  • Diabetes
  • Marked kidney problems (eGFR below 30mL/min/1.73 m2) or an arteriovenous fistula
  • Known pregnancy

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Subjects aged 21 to 85yo
  • Subjects or witnesses fluent in written and spoken French
  • Subjects agreeing to attend the study visit and follow study procedures
  • Subjects that have signed the informed consent form

Who cannot take part

  • Subjects with tachycardia (heart rate at rest > 120bpm)
  • Subjects with diabetes
  • Subjects with Raynaud's disease
  • Subjects with an arteriovenous fistula
  • History of polyneuropathy
  • Subjects with marked renal dysfunctions (eGFR < 30mL/min/1.73 m2)
  • Amputated index fingers
  • Damaged/injured skin at index fingers
  • Damaged/injured skin at wrists
  • Subjects with atrial fibrillation
  • Subjects with untreated hyper-/hypothyroidism
  • Subjects with pheochromocytoma
  • Women in known pregnancy

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 21 and 85 years old?

Where in Switzerland

  • CHUV Service de Néphrologie et d'HypertensionLausanne, SwitzerlandContact: Grégoire WUERZNER, Prof. Med.Taking people

About the trial

What the trial wants to find out

The present study, OBPM_COYOTE2024, with N = 255 participants minimum over 1 visit (lasting ~15min), has been designed to collect raw optical data with Aktiia.product-G2C Clinical investigational device together with Aktiia G2 Bracelet and Aktiia Init I1 oscillometric cuff within a cohort of subjects characterized by a wide variety of phenotypes. The resulting dataset will support research and development activities conducted by AKTIIA SA out of the study context.

The group in the trial

  • Aktiia G2C cohortOther group

    Study subjects are asked to stay seated while 3 successive measurements are taken with the Aktiia G2C device under investigation (BP and PR) and two references (Aktiia Bracelet G2 and Aktiia Init I1 oscillometric cuff).

    Treatment: Aktiia G2C

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
OBPM_COYOTE2024 Physiological Data Recording With the Calibration-free Optical Aktiia G2C Device at Fingertip and Wrist, Alongside the Aktiia Oscillometric Cuff: a Single-center, Prospective Clinical Study
Plain-language title
Comparing a wrist and fingertip blood pressure device with a cuff in adultsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT06698536, who can take part
Record updated
14 May 2025